Statutory Instruments Act (R.S.C., 1985, c. S-22)

Act current to 2019-07-01 and last amended on 2015-06-18. Previous Versions

RELATED PROVISIONS

  • — 2012, c. 19, s. 417

    • Interim marketing authorization
      • 417 (1) An interim marketing authorization that is issued under subsection 30.2(1) of the Food and Drugs Act and in effect immediately before the day on which section 416 comes into force continues to have effect until the earliest of

        • (a) the day on which the Minister of Health publishes a notice cancelling the interim marketing authorization in the Canada Gazette;

        • (b) the day on which a marketing authorization — or any part of it — that is issued under subsection 30.3(1) of the Food and Drugs Act, as enacted by section 416, has the same effect as the interim marketing authorization; and

        • (c) two years after the day on which the interim marketing authorization is published in the Canada Gazette.

      • Exemption from Statutory Instruments Act

        (2) A notice cancelling an interim marketing authorization is exempt from sections 3, 5 and 11 of the Statutory Instruments Act.

  • — 2012, c. 31, s. 96

    • 96 The Input Tax Credit Allocation Methods (GST/HST) Regulations are deemed

Date modified: